Cargando…

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease

Detalles Bibliográficos
Autores principales:	Panicker, Nikhil, Kanthasamy, Arthi, Kanthasamy, Anumantha G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738402/ https://www.ncbi.nlm.nih.gov/pubmed/31454793 http://dx.doi.org/10.18632/aging.102210

Ejemplares similares

Mitochondrial impairment in microglia amplifies NLRP3 inflammasome proinflammatory signaling in cell culture and animal models of Parkinson’s disease
por: Sarkar, Souvarish, et al.
Publicado: (2017)

Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia
por: Panicker, Nikhil, et al.
Publicado: (2019)

Fyn Kinase-Mediated PKCδ Y311 Phosphorylation Induces Dopaminergic Degeneration in Cell Culture and Animal Models: Implications for the Identification of a New Pharmacological Target for Parkinson’s Disease
por: Saminathan, Hariharan, et al.
Publicado: (2021)

Environmental neurotoxin dieldrin induces apoptosis via caspase-3-dependent proteolytic activation of protein kinase C delta (PKCdelta): Implications for neurodegeneration in Parkinson's disease
por: Kanthasamy, Anumantha G, et al.
Publicado: (2008)

Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (TWEAK) Enhances Activation of STAT3/NLRC4 Inflammasome Signaling Axis through PKCδ in Astrocytes: Implications for Parkinson’s Disease
por: Samidurai, Manikandan, et al.
Publicado: (2020)

Proteolytic activation of proapoptotic kinase protein kinase Cδ by tumor necrosis factor α death receptor signaling in dopaminergic neurons during neuroinflammation
por: Gordon, Richard, et al.
Publicado: (2012)

Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology
por: Malovic, Emir, et al.
Publicado: (2021)

Mitochondrial dysfunction–induced H3K27 hyperacetylation perturbs enhancers in Parkinson’s disease
por: Huang, Minhong, et al.
Publicado: (2021)

PKC Delta Activation Promotes Endoplasmic Reticulum Stress (ERS) and NLR Family Pyrin Domain-Containing 3 (NLRP3) Inflammasome Activation Subsequent to Asynuclein-Induced Microglial Activation: Involvement of Thioredoxin-Interacting Protein (TXNIP)/Thioredoxin (Trx) Redoxisome Pathway
por: Samidurai, Manikandan, et al.
Publicado: (2021)

Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease
por: Ghosh, Anamitra, et al.
Publicado: (2012)

Protein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degeneration
por: Asaithambi, Arunkumar, et al.
Publicado: (2011)

Neuroprotective Effect of Resveratrol Against Methamphetamine-Induced Dopaminergic Apoptotic Cell Death in a Cell Culture Model of Neurotoxicity
por: Kanthasamy, Kavin, et al.
Publicado: (2011)

Impact of Environmental Risk Factors on Mitochondrial Dysfunction, Neuroinflammation, Protein Misfolding, and Oxidative Stress in the Etiopathogenesis of Parkinson’s Disease
por: Huang, Minhong, et al.
Publicado: (2022)

N-Acetyl Cysteine Protects against Methamphetamine-Induced Dopaminergic Neurodegeneration via Modulation of Redox Status and Autophagy in Dopaminergic Cells
por: Chandramani Shivalingappa, Prashanth, et al.
Publicado: (2012)

Microglial immune regulation by epigenetic reprogramming through histone H3K27 acetylation in neuroinflammation
por: Huang, Minhong, et al.
Publicado: (2023)

Proteasome inhibitor-induced apoptosis is mediated by positive feedback amplification of PKCδ proteolytic activation and mitochondrial translocation
por: Sun, Faneng, et al.
Publicado: (2008)

Manganese-Induced Neurotoxicity: New Insights Into the Triad of Protein Misfolding, Mitochondrial Impairment, and Neuroinflammation
por: Harischandra, Dilshan S., et al.
Publicado: (2019)

Protein Kinase D1 (PKD1) Phosphorylation Promotes Dopaminergic Neuronal Survival during 6-OHDA-Induced Oxidative Stress
por: Asaithambi, Arunkumar, et al.
Publicado: (2014)

Integrated Organotypic Slice Cultures and RT-QuIC (OSCAR) Assay: Implications for Translational Discovery in Protein Misfolding Diseases
por: Kondru, Naveen, et al.
Publicado: (2017)

Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders
por: Padhi, Piyush, et al.
Publicado: (2022)

Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration
por: Gordon, Richard, et al.
Publicado: (2016)

Hepcidin Plays a Key Role in 6-OHDA Induced Iron Overload and Apoptotic Cell Death in a Cell Culture Model of Parkinson's Disease
por: Xu, Qi, et al.
Publicado: (2016)

An Ex Vivo Brain Slice Culture Model of Chronic Wasting Disease: Implications for Disease Pathogenesis and Therapeutic Development
por: Kondru, Naveen, et al.
Publicado: (2020)

The NLRP3-Inflammasome in Health and Disease
por: Perri, Anna
Publicado: (2022)

Phytic Acid Protects against 6-Hydroxydopamine-Induced Dopaminergic Neuron Apoptosis in Normal and Iron Excess Conditions in a Cell Culture Model
por: Xu, Qi, et al.
Publicado: (2011)

EGCG Protects against 6-OHDA-Induced Neurotoxicity in a Cell Culture Model
por: Chen, Dan, et al.
Publicado: (2015)

New protocol for kinetic assay seeding ability recovery “KASAR” from formalin-fixed paraffin-embedded tissues
por: Hepker, Monica, et al.
Publicado: (2023)

Chronic Manganese Exposure and the Enteric Nervous System: An in Vitro and Mouse in Vivo Study
por: Ghaisas, Shivani, et al.
Publicado: (2021)

Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity
por: Yen, Chi-Fu, et al.
Publicado: (2016)

Role of NLRP3 inflammasome in inflammatory bowel diseases
por: Tourkochristou, Evanthia, et al.
Publicado: (2019)

Status Epilepticus: Behavioral and Electroencephalography Seizure Correlates in Kainate Experimental Models
por: Sharma, Shaunik, et al.
Publicado: (2018)

Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
por: Nguyen, Linh Thi Nhat, et al.
Publicado: (2022)

Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

Cystic Fibrosis Lung Disease and Immunometabolism. Targeting the NLRP3 Inflammasome
por: Cantin, André M.
Publicado: (2019)

Fatty acid synthesis and NLRP3-inflammasome
por: Moon, Jong-Seok, et al.
Publicado: (2015)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

Saturated fatty acid-crystals activate NLRP3 inflammasome
por: Karasawa, Tadayoshi, et al.
Publicado: (2019)

The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
por: Han, Qiu-Qin, et al.
Publicado: (2023)

BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson’s disease
por: Ying, Zhong-Ming, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_08bo7g9fpav79ti6vi4d2irhjp